[Facial paralysis].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D001205:Ascorbic Acid / Q000627:therapeutic use; D003348:Cortisone / Q000627:therapeutic use; D004558:Electric Stimulation; D004576:Electromyography; D005154:Facial Nerve / Q000601:surgery; D005158:Facial Paralysis / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology*; D006801:Humans; D011239:Prednisolone / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D014276:Trigeminal Nerve; D014665:Vasodilator Agents / Q000627:therapeutic use; D014803:Vitamin B Complex / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D014665:Vasodilator Agents; D014803:Vitamin B Complex; D000324:Adrenocorticotropic Hormone; D011239:Prednisolone; D001205:Ascorbic Acid; D003348:Cortisone; D011241:Prednisone
Parálisis facial.